110550 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses; Methods of inactivation or attenuation by genetic engineering
Polynucleotides for use in AAV production
#2MODULATORS OF ADENO-ASSOCIATED VIRUS TRANSDUCTION AND USES THEREOF
#3CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#4Restrictive inverted terminal repeats for viral vectors
#5MODIFIED ADENO-ASSOCIATED VIRUS (AAV) PARTICLES FOR GENE THERAPY
#6Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#7ADENO-ASSOCIATED VIRAL VECTOR PRODUCER CELL LINES
#8Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#9AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#10METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY
#11Restrictive inverted terminal repeats for viral vectors
#12Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#13Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#14Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#15AAV virions with decreased immunoreactivity and uses therefor
#16CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#17CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#18CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#19CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#20Restrictive inverted terminal repeats for viral vectors
#21Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#22AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#23CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#24Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#25CNS targeting AAV vectors and methods of use thereof
#26Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#27Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#28AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#29Restrictive inverted terminal repeats for viral vectors
#30Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#31CNS targeting AAV vectors and methods of use thereof
#32CNS targeting AAV vectors and methods of use thereof
#33Restrictive inverted terminal repeats for viral vectors
#34Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#35METHOD FOR GENERATING REPLICATION DEFECTIVE VIRAL VECTORS THAT ARE HELPER FREE
#36Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#37Method for detecting adeno-associated virus
#38High-efficiency wild-type-free AAV helper functions
#39AAV virions with decreased immunoreactivity and uses therefor
#40Modified baculovirus expression system for production of pseudotyped rAAV vector
#41High-efficiency wild-type-free AAV helper functions
#42AAV virions with decreased immunoreactivity and uses therefor
#43High-efficiency AAV helper functions